Cible's Incubator/Accelerator Round

Cible raised a round of funding on July 01, 2017. Investors include JLabs.

Cible is a preclinical-stage cancer drug company that solves the major problems of traditional cancer therapy through the implementation of a smart drug platform. The first lead candidate, oxaliTEX, i…

Articles about Cible's Incubator/Accelerator Round: